Invesaro

Stocks NRIX Earnings

Earnings

Nurix Therapeutics, Inc. (NRIX) earnings

Quarterly results of Nurix Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when NRIX files with the SEC.

Next earnings date

Nurix Therapeutics, Inc. is expected to report around January 27, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended August 31, 2026) Nurix Therapeutics, Inc. reported revenue of $673.1M (+8,426.3% on the same quarter a year earlier) and net income of $549.8M.

Diluted earnings per share were $4.73.

Filed with the SEC on October 13, 2026.

Revenue by quarter
Q4 24: $13.3M $13.3M Q4 24Q1 25: $18.5M $18.5M Q1 25Q2 25: $44.1M $44.1M Q2 25Q3 25: $7.9M $7.9M Q3 25Q4 25: $13.6M $13.6M Q4 25Q1 26: $6.3M $6.3M Q1 26Q2 26: $9M $9M Q2 26Q3 26: $673.1M $673.1M Q3 26
Net income by quarter
Q4 24: -$58.5M -$58.5M Q4 24Q1 25: -$56.4M -$56.4M Q1 25Q2 25: -$43.5M -$43.5M Q2 25Q3 25: -$86.4M -$86.4M Q3 25Q4 25: -$78.2M -$78.2M Q4 25Q1 26: -$87.2M -$87.2M Q1 26Q2 26: -$89.5M -$89.5M Q2 26Q3 26: $549.8M $549.8M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026August 31, 2026$673.1M+8,426.3%$549.8M$4.73
Q2 FY2026May 31, 2026$9M-79.5%-$89.5M-$0.81
Q1 FY2026February 28, 2026$6.3M-66.1%-$87.2M-$0.79
Q4 FY2025November 30, 2025$13.6M+2.2%-$78.2M-
Q3 FY2025August 31, 2025$7.9M--$86.4M-$1.03
Q2 FY2025May 31, 2025$44.1M--$43.5M-$0.52
Q1 FY2025February 28, 2025$18.5M--$56.4M-$0.67
Q4 FY2024November 30, 2024$13.3M--$58.5M-

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Nurix Therapeutics, Inc.'s next earnings date?

Nurix Therapeutics, Inc. is expected to report around January 27, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Nurix Therapeutics, Inc.'s latest quarterly results?

For Q3 FY2026, which ended August 31, 2026, Nurix Therapeutics, Inc. reported revenue of $673.1M and net income of $549.8M. The figures come from its filing with the SEC.

Is Nurix Therapeutics, Inc.'s revenue growing?

Revenue in Q3 FY2026 was $673.1M, up 8,426.3% from $7.9M in the same quarter a year earlier.

Get an email when NRIX reports

Follow NRIX and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when NRIX files with the SEC.

Source: quarterly figures Nurix Therapeutics, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Nurix Therapeutics, Inc.